ICUI logo

ICU Medical Stock Price

Symbol: NasdaqGS:ICUIMarket Cap: US$3.2bCategory: Healthcare

ICUI Share Price Performance

US$126.89
5.10 (4.19%)
31.9% undervalued intrinsic discount
US$186.20
Fair Value
US$126.89
5.10 (4.19%)
31.9% undervalued intrinsic discount
US$186.20
Fair Value
Price US$126.89
AnalystConsensusTarget US$186.20

ICUI Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value US$186.20 31.9% undervalued intrinsic discount

Aging Populations And Emerging Markets Will Expand Hospital Care

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent ICUI News & Updates

No updates

ICU Medical, Inc. Key Details

US$2.4b

Revenue

US$1.6b

Cost of Revenue

US$849.6m

Gross Profit

US$943.3m

Other Expenses

-US$93.7m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 07, 2025
Earnings per share (EPS)
-3.81
Gross Margin
35.11%
Net Profit Margin
-3.87%
Debt/Equity Ratio
77.3%

ICU Medical, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About ICUI

Founded
1984
Employees
15000
CEO
Vivek Jain
WebsiteView website
www.icumed.com

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company’s customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

U.S. Market Performance

  • 7 Days: -0.2%
  • 3 Months: 12.2%
  • 1 Year: 22.4%
  • Year to Date: 7.7%
Over the last 7 days, the market has remained flat, although notably the Communication Services sector gained 3.4% in that time. As for the longer term, the market has risen 22% in the past 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading